Irbesartán Sun

Irbesartan, the active ingredient in Irbesartán Sun, is an Angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It reduces blood pressure and slows progression of kidney damage in adults with hypertension, including those who have type 2 diabetes‑related nephropathy.

GNH USA supplies Irbesartán Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to quality‑assured medicines across regulated markets.

Irbesartan is used to manage conditions related to the renin‑angiotensin system, primarily hypertension and diabetic kidney disease.

- Hypertension: lowers elevated blood pressure, helping to prevent cardiovascular complications. - Diabetic nephropathy: slows the decline of renal function in patients with type 2 diabetes‑related kidney disease. - Proteinuria: reduces urinary protein excretion, contributing to renal protection.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Headache: mild to moderate head pain. - Fatigue: feeling unusually tired or weak. - Nasal congestion: blocked or runny nose. - Back pain: discomfort in the lower back region. - Increased serum creatinine: modest rise in kidney function marker.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or throat that may impair breathing. - Hyperkalemia: elevated potassium levels that can affect heart rhythm. - Acute renal failure: sudden loss of kidney function. - Hepatic injury: signs of liver damage such as jaundice or elevated enzymes.

Before starting Irbesartán Sun, patients and clinicians should consider several safety measures. - Blood pressure monitoring: check regularly to ensure therapeutic control. - Renal function assessment: evaluate serum creatinine and eGFR at baseline and periodically. - Serum potassium: monitor for hyperkalemia, especially if using potassium‑sparing agents. - Pregnancy: avoid use in pregnancy due to fetal risk (Category D). - Hepatic impairment: use with caution in patients with liver disease. - Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Irbesartán Sun may interact with other medicines; awareness of the interaction level guides management.

Major Interactions (Avoid): - Aliskiren in diabetic patients: combined use can increase renal risk. - Dual blockade with ACE inhibitors or other ARBs: may cause excessive hypotension and renal dysfunction. - Potassium‑sparing diuretics (e.g., spironolactone): heightens risk of hyperkalemia. - NSAIDs (high dose): can impair renal function and blunt antihypertensive effect.

Moderate Interactions (Monitor Closely): - Thiazide diuretics: may enhance antihypertensive effect, requiring dose adjustment. - Lithium: increased lithium levels, necessitating serum monitoring.